BB Biotech as of June 30, 2011
Portfolio Holdings for BB Biotech
BB Biotech holds 19 positions in its portfolio as reported in the June 2011 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 23.0 | $245M | 4.1M | 60.32 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 16.0 | $171M | 3.3M | 51.99 | |
Gilead Sciences (GILD) | 13.3 | $142M | 3.4M | 41.41 | |
Incyte Corporation (INCY) | 8.1 | $87M | 4.6M | 18.94 | |
ImmunoGen (IMGN) | 4.5 | $48M | 3.9M | 12.19 | |
Dendreon Corporation | 4.3 | $46M | 1.2M | 39.44 | |
ISIS Pharmaceuticals | 4.2 | $45M | 4.9M | 9.16 | |
Micromet | 3.6 | $38M | 6.7M | 5.74 | |
Amylin Pharmaceuticals | 3.4 | $36M | 2.7M | 13.36 | |
Halozyme Therapeutics (HALO) | 3.2 | $35M | 5.0M | 6.91 | |
Amgen (AMGN) | 2.7 | $29M | 500k | 58.35 | |
BioMarin Pharmaceutical (BMRN) | 2.5 | $27M | 976k | 27.21 | |
Optimer Pharmaceuticals | 2.3 | $24M | 2.0M | 11.89 | |
Alexion Pharmaceuticals | 2.3 | $24M | 514k | 47.03 | |
Human Genome Sciences | 2.0 | $21M | 871k | 24.54 | |
Idenix Pharmaceuticals | 1.4 | $16M | 3.1M | 5.00 | |
Theravance | 1.4 | $15M | 663k | 22.21 | |
Achillion Pharmaceuticals | 0.9 | $9.9M | 1.3M | 7.44 | |
Affymetrix | 0.8 | $8.1M | 1.0M | 7.93 |